Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference5 articles.
1. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of literature;Abdel-Wahab;J Immunother Cancer,2019
2. Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?;De Bruyn;Curr Opin Oncol,2019
3. Use of checkpoint inhibitors in liver transplant recipients;Munker;United European Gastroenterology Journal,2018
4. Immune checkpoint inhibitors in organ transplant patients;Kittai;J Immunother,2017
5. Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective;Ho;Ther Adv Med Oncol,2019
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing the Power of Immunotherapy in Liver Transplantation for HCC;Current Transplantation Reports;2024-07-03
2. Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors;Cancers;2024-06-28
3. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update;Journal of Clinical Oncology;2024-05-20
4. Anti-PD-1 therapy reverses TIGIT+CD226+NK depletion in immunotherapy resistance of hepatocellular carcinoma through PVR/TIGIT pathway;International Immunopharmacology;2024-03
5. Immunotherapy and Liver Transplantation;Surgical Clinics of North America;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3